VHA
Lemon SM. HAV: current concepts of the molecular virology; immunobiology, and approaches to vaccine development.; Rev Med Virol, 2, 73-87
Feinstone SM, Kapikian AZ, Purcell RH.; Detection by immune electron microscopy of a virus like antigen associated with acute illness.; Science 1973, 182, 1026
Gordon S, Reddy K, Schiff L, Schiff ER.; Prolonged intrahepatic cholestasis secondary to acute hepatitis A.; Ann Intern Med, 1984, 101, 635-637
Glikson M, Galun E, Oren R, Tur-Kaspa R,Shouval D.; Relapsing hepatitis A.; Revieuw of 14 cases and literature survey. Medicine, 1992, 71, 14-23
Vento S, Garofano T, Di Perri G, Dolci L, Concia R, Bassetti D.; Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis 1 in susceptible individuals.; Lancet, 1991, 337, 1183-1187
Andre F, d'Hondt E, Delem A, Safary A.; Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine.; Rationale and summary of findings.Vaccine, 1992, 10, S160-S168
VHB
1 R Wright et al.; Acute viral hepatitis. In Liver and biliary disease. Wright, Millward-Sadler, Alberti, Karran. Baillière Tindall. 1985, 677-696
R Brenard.; Apports récents de la biologie moléculaire dans le diagnostic des hépatites dues au virus B. Acta Gastroenterologica Belgica. 1993, 56, 18-23
Ganem D., Varmus H.E.; The molecular biology of the hepatitis B viruses. Ann.; Rev. Biochem., 1987, 56, 651-694.
Tiollais P., Pourcel C., Dejean A. ; The hepatitis B virus.; Nature, 1985, 317, 489-495.
Michel M.L., Tiollais P.; Structure and expression of the hepatitis B virus genome.; Hepatology, 1987, 7, 61S-63S.
Gerber M., Thung S.; Molecular and cellular pathology of hepatitis B. Lab. ; Invest., 1985, 52, 572-590.
Foster G.R., Carman W.F., Thomas H.C.; Replication of hepatitis B and Delta viruses: Appearance of viral mutants. Sem.; Liver Dis., 1991, 11/2, 121-127.
Foster G.R., Thomas H.C.; Recent advances in the molecular biology of hepatitis B virus: mutant virus and the host response.;Gut, 1993, 34, 1-3.
2
Beutels M., Van Damme P., Aelvoet W. et al.; Prevalence of hepatitis A, B and C in the flemish population.; Eur J Epidemiol 1997, 13: 1-6.
Centers for Disease Control. General recommandations on immunisation.; MMWR 1994, 43, RR1, 6-7.
Devroey D., Van Casteren V., Vranckx R.; Klinische acute virale hepatitis in de Belgische Huisartsenpraktijk - registratie van de huisartsenpeilpraktijken. Resultaten van 1991 en 1992. ; Rapport Instituut voor Hygiëne en Epidemiologie, Brussel, november 1996.
Beutels M., Van Damme P., Aelvoet W. et al. Prevalence of hepatitis A, B and C in the flemish population. Eur J Epidemiol 1997, 13: 1-6.
Centers for Disease Control. General recommandations on immunisation. MMWR 1994, 43, RR1, 6-7.
Devroey D., Van Casteren V., Vranckx R. Klinische acute virale hepatitis in de Belgische Huisartsenpraktijk - registratie van de huisartsenpeilpraktijken. Resultaten van 1991 en 1992. Rapport Instituut voor Hygiëne en Epidemiologie, Brussel, november 1996.
Gerberding J.L. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995, 332, 444-451.
Kane M.A., Clements J., Hu D. Hepatitis B. In: Jamison D.T., Mosley W.H., Measham A.R et al. (eds). Disease control priorities in developing countries. A World Bank Book. New York, Oxford University Press, 1993: 321-330.
Van Damme P., De Groote K., Deprettere A., Michielsen P. Hepatitis B in België: epidemiologie en vaccinatiebeleid. Tijdschr v Geneesk 1997 (in press).
Dusheiko G, Hoofnagle JH. Hepatitis B. In: Mc Intyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press 1991: 571-592.
Koff RS. Viral hepatitis. In: Schiff L, Schiff E, eds. Diseases of the liver. Phyladelphia: JP Lippincott Company 1993: 492-577
Scheveitzer IL. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci 1975; 270: 287-292
Ip H, Lelie P, Wong V, Kuhns M, Reesink H. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1: 406-410
Margolis H, Alter M, Hadler S. Hepatitis B: Evolving epidemiology and implications for control. Sem Liv Dis 1991; 11:84-92
3
Beutels M., Van Damme P., Aelvoet W. et al. ; Prevalence of hepatitis A, B and C in the flemish population. Eur J Epidemiol 1997, 13: 1-6.
Centers for Disease Control. General recommandations on immunisation. MMWR 1994, 43, RR1, 6-7.
Devroey D., Van Casteren V., Vranckx R.; Klinische acute virale hepatitis in de Belgische Huisartsenpraktijk - registratie van de huisartsenpeilpraktijken. Resultaten van 1991 en 1992. Rapport Instituut voor Hygiëne en Epidemiologie, Brussel, november 1996.
Gerberding J.L. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995, 332, 444-451.
Kane M.A., Clements J., Hu D. Hepatitis B. In: Jamison D.T., Mosley W.H., Measham A.R et al. (eds). Disease control priorities in developing countries. A World Bank Book. New York, Oxford University Press, 1993: 321-330.
Van Damme P., De Groote K., Deprettere A., Michielsen P. Hepatitis B in België: epidemiologie en vaccinatiebeleid. Tijdschr v Geneesk 1997 (in press).
Dusheiko G, Hoofnagle JH. Hepatitis B. In: Mc Intyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford textbook of clinical hepatology. Oxford: Oxford University Press 1991: 571-592.
Koff RS. Viral hepatitis. In: Schiff L, Schiff E, eds. Diseases of the liver. Phyladelphia: JP Lippincott Company 1993: 492-577.
Scheveitzer IL. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci 1975; 270: 287-292.
Ip H, Lelie P, Wong V, Kuhns M, Reesink H. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1989; 1: 406-410.
Margolis H, Alter M, Hadler S. Hepatitis B: Evolving epidemiology and implications for control. Sem Liv Dis 1991; 11:84-92.
Jonhson R, Couser W. Hepatitis B infection and renal diseases: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37: 663-676.
Guillevin L, Lhote F, Cohen P et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long term observation in 41 patients. Medecine 1995; 74: 238-253.
Lai K, Li P, Lui S et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 1991; 324: 1457-63.
Gilbert R, Wiggelinkhuizen J. The clinical course of hepatitis B virus associated-nephropathy. Pediatr Nephrol 1994; 8: 11-14.
Lee H, Choi Y Yu S et al. A renal biopsy study of hepatitis B virus associated nephropathy in Korea. Kidney Int 1988;34: 537-43.
Lin C. Hepatitis B virus deoxyribonucleic acid in kidney cells probably leading to viral pathogenesis among hepatitis B virus associated membranous nephropathy patients. Nephron 1993; 63: 58-64.
Lin C. Treatment of hepatitis B virus associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 1995; 47: 225-30.
Iida H, Izumino K, Asaka M et al. Ig A nephropathy and hepatitis B virus. Nephron 1990; 54: 18-20.
Lai K, MacMounes S, Lai F et al. The clinicopathologic features of hepatitis B virus associated glomerulonephritis. Q J Med 1987; 63: 323-33.
4
Thomas HC, Carman WF. Envelope and precore/core variants of hepatitis B virus. Gastrenterol. Clin. North Am. 1994; 23: 499-514.
Carman WF, Thomas HC. Genetic variation in hepatitis B virus. Gatroenterology 1992; 102: 711-719.
Naoumov NV, Schneider R, Grötzinger T et al. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992; 102: 538-543.
Bonino F, Brunetto MR. Hepatitis B virus heterogeneity, one of many factors influencing the severity of hepatitis B. J. Hepatol. 1993; 18: 5-8.
Brunetto MR, Stemler M, Bonino F, et al. A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J. Hepatol. 1990; 10: 258-261.
Kosaka Y, Takase K, Kojima M, et al. Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. Gastroenterology 1991; 100: 1087-1094.
Liang TJ, Hasegawa K, Rimon N, et al. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N. Engl. J. Med. 1991; 324: 1705-1709.
Zarski JP, Marcellin P, Cohard M, et al. Comparison of anti-HBe- positive and HBe-antigen-positive chronic hepatitis B in France. J. Hepatol. 1994; 20: 636-640.
5
Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology, 1982, 83, 338-340.
McAfee J, Keeffe E, Randall G, Rösch J. Transjugular liver biopsy. Hepatology, 1992, 15, 726-732.
Brenard R, Horsmans Y, Rahier J, Druez P, Descamps Ch, Geubel A. Transvenous liver biopsy: an experience based on 500 procedures. Acta Gastroenterologica Belgica. 1997, 60, 138-141.
RNM Mc Sween, PP Anthony, PJ Scheuer: Pathology of the liver - Second edition - Churchill Livingstone, 1987
Scheuer PJ: Liver biopsy interpretation - 5th edition London: Bailliere Tindall, 1996.
Snover DC: Biopsy diagnosis of liver disease - Williams & Wilkins, 1992
Sheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM: The pathology of hepatitis C - Hepatology 1992; 15: 567-571
Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis - Hepatology 1992; 15: 572-577
Lefkowitch JH, Schiff ER, Davis GL et al.: Pathological diagnosis of hepatitis C: a multicenter comparative study with chronic hepatitis B - Gastroenterology 1993; 104: 595-603
Dhillon AP, Dusheiko GM: Pathology of hepatitis C virus infection - Histopathology 1995; 26: 297-309
Yap SH, Willems M, Van den Oord J, Habets W, Middeldorp JM, Hellings JA, Nevens F, Moshage H, Desmet V and Fevery J: Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection - J Hepat 1994; 20: 275-281
Kojima S, Tanaka Y, Enomoto N, Marumo F, Sato C: Distribution of hepatitis C virus RNA in the liver and its relation to histopathological changes - Liver 1996; 16: 55-60
Nuovo GJ, Lidonnici K, Macconnell P, Lane B: Intracellular localisation of polymerase chain reaction (PCR) - amplified hepatitis C cDNA - Am J Surg Pathol 1993; 17: 683-690
De Groote J, Desmet VJ, Gedigk P , Korb G, Popper H, Poulsen H et al.: A classification of chronic hepatitis - Lancet 1968;2: 626-628
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnostic, grading and staging - Hepatology 1994; 19: 1513-1520
International Working Party. Terminology of chronic hepatitis, hepatic allograft rejection and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los-Angeles, 1994. Am J Gastroenterol 1994; 89: S 177-S 181
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis - Hepatology 1981; 1: 431-435
Ishak K, Baptista A, Bianchi L et al.: Histological grading and staging of hepatitis - J Hepatology 1995; 22: 696-699
Bedossa P: Présentation d’une grille analytique informatisée pour le recueil des lésions histopathologiques dans l’hépatite chronique virale C. Etude coopérative du groupe METAVIR - Ann Pathol 1993; 13: 260-265
Bedossa P., Bioulac-Sage P, Callard P, Chevallier M, Degott C; Deugnier Y, Fabre M, Reynes M, Voigt JJ et Zafrani E: Quelle classification pour les hépatites chroniques ? Les leçons du virus de l’hépatite C - Groupe METAVIR Gastroenterol Clin Biol 1994; 18: 403-406
Davies SE, Portmann BC, O’Grady JG, et al.: hepatic histological findings after liver transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis - Hepatology 1991; 13:150-157
Walker N, Apel R, Kerlin P et al. : Hepatitis B virus infection in liver allografts - Am J Surg Pathol 1993; 17:666-667
O’Grady JG, Smith HM, Davies SE et al.: Hepatitis B reinfection after orthotopic liver transplantation . Serological and clinical implication. J Hepatol 1992;14:104-111
Jamal H, Regenstein F, Farr G, Perillo RP: Prolonged survival in fibrosing cholestatic hepatitis with long-term Ganciclovir therapy - Am J Gastroenterol 1996; 91: 1027-1030
Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J: Hepatitis C viral infection in liver transplant recipients - Hepatology 1992; 16: 865-876
Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS: Histologic progression of recurrent hepatitis C in liver transplant allografts - Am J Surg Pathol 1996; 20: 731-738
Gane EJ, Portmann BC, Naoumov NV et al.: Long-term outcome of hepatitis C infection after liver transplantation - N Eng J Med 1996; 334: 815-820
Dickson RC, Caldwell SH, Ishitani MB et al.: Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation - Transplantation 1996; 61: 701-705
6
Van Damme P., Meheus A., Kane M.A. Integration of hepatitis B vaccination into national immunisation progammes by 1997: how far are we? Br Med J 1997, 314: 1033-1037.
Van Damme P. Hepatitis B. In: Vaccinaties. Gids voor hedendaagse immunisatie. Vandepitte J., Wauters G., Pellegrims E. (eds), Garant, Leuven, Apeldoorn, 1995: 89-106.
Okamoto H., Yano K., Nozaki Y. et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immunoglobulin and vaccine. Pediatr Res 1992, 32, 264-268.
Hollinger F.B. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommandations. Am J Med 1989, 87 (suppl 3A), 36S-41 S.
Kane M.A. Global status of hepatitis B immunisation Lancet 1996, 348, 696.
Beutels P., Tormans G., Van Damme P., Van Doorslaer E. Universele hepatitis B vaccinatie in Vlaanderen: kosten-effectief? Tijdschr v Sociale Geneesk 1996, 74: 272-281.
7
Renault PF, Hoofnagle JH. Side effects of alpha interferon. Sem Liv Dis, 1989, 9, 273-277.
Vial T, Bailly F, Descotes J, Trepo C. Effets secondaires de l’interféron alpha. Gastroenterol Clin Biol. 1996, 20, 462-489.
Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol. 1995, 22, 364-369.
Lisker-Melman M, Di Bisceglie A, Usala S, Weintraub B, Murray L, Hoofnagle J. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology, 1992, 102,2155-2160.
Quesada J, Talpaz M, Rios A, Kurzrock R, Gutterman J. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol, 1986, 4, 234-243.
Marcellin P, Colin JF, Boyer N, Bernuau J, Degott C, Hirschauer, et al. Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet, 1991, 338, 82.
Janssen H, Brouwer J, Nevens F, Sanchez-Tapias J, Craxi A, Hadziyannis S. Fatal hepatic decompensation associated with interferon alpha. Lancet, 1993, 306, 107-108.
Papo T, Marcellin P, Bernuau J, Durand F, Poynard T et al. Autoimmune chronic hepatitis exacebed by alpha-interferon. Ann Int Med, 1992, 116, 51-53.
Janssen H, Brouwer J, van der Mast R, Schalm S. Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J Hepatol, 1994, 21, 241-243.
Renault P, Hoofnagle J, Park Y, Mullen K, Peters M, Jones B et al. Psychiatric complications of long-term interferon alpha therapy. Arch Intern Med, 1987, 147, 1577-1578
8
Perillo R, et al. Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. Ann Intern Med. 1988 ; 109 : 95-100.
Perillo R. Factors influencing response to interferon in chronic hepatitis B : Implication for Asian and Western populations. Hepatology. 1990 ; 12: 1433-1435.
Korenman J, et al. Long term remission of chronic hepatitis B after alpha interferon therapy. Ann Intern Med. 1991; 114: 629-634.
Carreno vet al. Long term effect of interferon therapy in chronic hepatitis B. J Hepatol, 1994; 20: 431-435.
Perez V, et al. A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B : long term follow up. Gut 1993; Supplement: S91 - S94.
Di Bisceglie, et al. A randomized controlled trial of recombinant alpha interferon therapy for chronic hepatitis B. Am J Gastro. 1993; 88: 1887-1892.
Wong D, et al. Effect of alpha interferon treatment in patients with hepatitis B e Antigen - positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993; 119: 312-323.
Hoofnagle J. Lau D. Chronic viral hepatitis - benefits of current therapies. N Engl J Med. 1996; 334: 1471-1472.
Niederau C et al. Long term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitius B. N Engl J Med 1996, 334: 1422-1427.
VHC
1
Bréchot C. Virus de l'hépatite C? Structure et variabilité génétique. Ann Gastroentérol Hépatol. 1997, 33, 5-15.
Kaito M, Watanabe S, Tsukiyama K et al. Hepatitis C virus particle detected by immunoelectron microscopie study. J General Virology 1994; 75: 1755-1760.
Matsuura Y, Miyamura T. The molecular biology of hepatitis C virus. Virology 1993; 297-304.
Mc Omish F, Yap P, Dow B et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiology 1994: 32: 884-892.
Pol S, Thiers V, Nousbaum J.B, Legendre C, Berthelot P, Kreis H, Bréchat C. Changing distribution of HCV genotypes in Europe in the last decades. J Hepatol 1994; 21: S13.
Qu D, Li J, Vitviski L et al. Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type 1 and type 2. J Hepatol 1994; 21: 70-75.
Simmonds P. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994, 19, 1321-1324.
Weiner A, Geysen H. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA. 1992, 89, 3468-3472.
2
Donahue, N Engl J Med 1992; 327:369-373.
Lucidarme, Gastroenterol Clin Biol 1994; 18 : 64-68.
Conry-Cantilena, N Engl J Med 1996; 26: 1191-1196.
Chiaramonte, J Hepatol 1996; 24 : 129-134.
Jadoul, Kidney Int 1993; 44 : 1322-1326.
Bereira, Lancet 1995; 345 : 484-487.
Birnie, GUT 1983; 24 : 171-174.
Spach, Ann Intern Med 1993; 118 : 117-128.
Ray, Gastroenterol Clin Biol 1995; 19: 346-349.
Andrieu, Gastroenterol Clin Biol 1995; 19: 340-345.
René, Gastroenterol Clin Biol 1996; 20: 109-111.
MacDonald, Epidemiol Rev 1996; 18: 137-148.
Maillard, Gastroenterol Clin Biol 1996; 20: 1053-1057.
Akahane, Ann Intern Med 1994; 120: 148-152.
Coltorti, Infection 1994; 22: 183-186.
Epeirier, Gastroenterol Clin Biol 1996; 20: A 158.
Riestra, J Hepatol 1995; 22: 509-510.
Polywka, Eur J Clin Microbiol Infect Dis 1997; 16: 121-124.
Hoofnagle, 32ème meeting de l'EASL, Londres, 9-12 avril 1997.
Conférence de consensus, Gastroenterol Clin Biol 1997; 20: S202-S211
3
Lacour JP, Bodokh I, Castanet J, Bekri S et al. Porphyria cutanea tarda and antibodies of hepatitis C virus. Br. J. Dermatol. 1993, 128, 121-123
Fargion S, Piperno A, Cappelini M, Sampietro M et al. Hepatitis C virus and porphyria cutanea tarda. Evidence of a strong association. Hepatology 1992, 16, 1322-1326
Aceti A, Tliani G, Sorice M, Amendolea M. HCV and Sjögren's syndrome. Lancet 1992, 339, 1425-1426
Rebora A, Rongioletti F. Lichen planus and chronic active hepatitis. A retrospective survey. Acta. Derm. Venereol. (Stockh) 1984, 64, 52-56
D'Agay-Abensour L, Benamouzig R, De Belilvosky C, Cordoliani F. Lichen plan au cours d'une hépatite virale chronique C traitée par interféron alpha. Gastroenterol. Clin. Biol. 1992, 16, 610-611
Doutre M, Beylot C, Couzigou P, Long P et al. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy. Dermatology 1992, 184: 229
Gruppo Italiano Studi Epidemiologici in Dermatologia. Lichen planus and liver diseases : a multicentre case-control study. BMJ 1990, 300, 227-230
Mobacken H, Nilsson L, Olsson R, Sloberg K.Incidence of liver disease in chronic lichen planus of the mouth. Acta. Derm. Venereol. (Stockh) 1984, 64, 70-73
Divano M, Parodi A, Rebora A, Deplano A. Lichen planus, liver-kidney microsomal antibodies and hepatitis C virus. Dermatology 1992, 185, 132-133
Haddad J, Deny P, Muntz-Gotheil C, Ambrosini JC et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992, 339, 321-323
Alamasio P, Provenzano G, Scimeni M, Cascio G et al. Hepatitis C virus and Sjögren's syndrome. Lancet 1992, 339, 989-990
Cacoub P, Lunel F., Du L. Polyarteritis nodosa and hepatitis C virus infection. Ann. Intern. Med. 1992, 116, 605-606
Roth D. Hepatitis C virus: the nephrologist’s view. Am J Kidney Dis 1995; 25: 3-16
Lunel F. Hépatite C et anomalies immunologiques. Gastroenterol Clin Biol 1994; 18: 829-38
Jonhson R, Gretch D, Yamabe H et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70
D’Amico G, Fornasiere A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995; 25: 361-9
Jonhson R, Gretch D, Couser W et al. Hepatitis C virus-associated glomerulonephritis. Effect of a-interferon therapy. Kidney Int 1994; 46: 1700-1704
Sansonno D, Gesualdo L, Manno C et al. Hepatitis C virus related proteins in kidney tissue from hepatitis C virus infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997; 25: 1237-44
Larson C, Conn D, Czaja A et al. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20: 304-309
Tran A, Quaranta J, Benzaken S et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993, 18, 253-257.
Pateron D, Hartmann D, Duclos Valee JC, Jouanolle H, Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992, 16: 244-245.
uang M-J, Liaw Y. Clinical association between thyroid and liver diseases. J Gastroenterol Hepatol 1995, 10, 344-350
Marcellin P, Pouteau M, Benhamou JP. Hepatitis C, virus infection, interferon therapy and thyroid dysfunction. J Hepatol 1995, 22, 364-369
Allison M, Wreghitt T, Palmer C, Alexander G. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994, 21,1135-1139.
Ferri C, Greco F, Longombardo G, Palla P, et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinæmia. Arthritis. Rheum. 1991, 34, 1606-1610
Misiani R, Bellavita P, Fenili D, Boreli G, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinæmia. Ann Int Med 1992, 117, 573-577
Agnello V, Chung R, Kaplan L. A role for hepatitis C virus infection in type II cryoglobulinæmia. N Engl J Med 1992, 327, 1490-1495
Marcellin P, Descamps V, Martinot-Peignoux M et al. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993, 104, 272-277
Lunel F, Musset L, Cacoub P et al. Cryoglobulinemia in chronic liver disease: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106, 1291-1300
Karlsberg P, Lee W, Casey D et al. Cutaneous vasculitis and rhumatoïd factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia. Arch Dermatol 1995, 131, 1119-1123
Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990, 335, 258-259.
Bianchi FB. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 1993, 18, 273-275.
Duclos-Vallée JC, Yamamoto AM, Buffet C, Alvarez F. Les hépatites chroniques associées aux anticorps anti-microsomes de foie et de rein (anti-LKM1). Hépato-Gastro. 1997, 3, 189-194.
Knodell, Gastroenterology, 1997; 72: 902-909.
Berman, Ann Inter Med, 1979; 91-96.
Resnick, Dig Dis Sci, 1983; 28: 908-911.
Trinchet, gastroenterol clin biol,1997; 21: Al99.
Kiyosawa, Intervirology 1994; 37:101-107.
Sheen, J Hepatol 1996; 24: 525-531.
Lenzi M, Ballardini G, Fusconi M, Cassani F, Selleri L, Volta U et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990, 335, 258-259.
Bianchi FB. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus. J Hepatol 1993, 18, 273-275.
Duclos-Vallée JC, Yamamoto AM, Buffet C, Alvarez F. Les hépatites chroniques associées aux anticorps anti-microsomes de foie et de rein (anti-LKM1). Hépato-Gastro. 1997, 3, 189-194.
4
Marcellin P., Erlinger S. Clinique et évolution de l’hépatite C. Ann Gastroenterol Hepatol. 1997, 33, 29-33
De Medina M., Schiff ER. Hepatitis C: diagnosis assays. Sem Liv Dis. 1995, 15, 33-40
Fong T, Shindo M, Feinstone S et al. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest. 1991, 88, 1058-1060
Kobayashi M, Kumada H, Arase Y et al. The HCV-bDNA probe methid for measurement of HCV RNA counts by HCV genotype. Intern Hepatol Com. 1994, 2, 213-217
Simmonds P. Variability of hepatitis C virus. Hepatology 1995, 21, 570-583
Struyver L, Rosseau R, Wyseur A et al. Typing of HCV isolates and characterisation of new (sub)types using a line probe assay. J General Virol. 1993, 74, 1093-1102
Buisson Y, Teyssou R. Diagnostic biologique des infections à VHC. Ann Gastroenterol Hepatol. 1997, 33, 17-22
5
RNM Mc Sween, PP Anthony, PJ Scheuer: Pathology of the liver - Second edition - Churchill Livingstone, 1987
Scheuer PJ: Liver biopsy interpretation - 5th edition London: Bailliere Tindall, 1996.
Snover DC: Biopsy diagnosis of liver disease - Williams & Wilkins, 1992
Sheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM: The pathology of hepatitis C - Hepatology 1992; 15: 567-571
Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis - Hepatology 1992; 15: 572-577
Lefkowitch JH, Schiff ER, Davis GL et al.: Pathological diagnosis of hepatitis C: a multicenter comparative study with chronic hepatitis B - Gastroenterology 1993; 104: 595-603
Dhillon AP, Dusheiko GM: Pathology of hepatitis C virus infection - Histopathology 1995; 26: 297-309
Yap SH, Willems M, Van den Oord J, Habets W, Middeldorp JM, Hellings JA, Nevens F, Moshage H, Desmet V and Fevery J: Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection - J Hepat 1994; 20: 275-281
Kojima S, Tanaka Y, Enomoto N, Marumo F, Sato C: Distribution of hepatitis C virus RNA in the liver and its relation to histopathological changes - Liver 1996; 16: 55-60
Nuovo GJ, Lidonnici K, Macconnell P, Lane B: Intracellular localisation of polymerase chain reaction (PCR) - amplified hepatitis C cDNA - Am J Surg Pathol 1993; 17: 683-690
De Groote J, Desmet VJ, Gedigk P , Korb G, Popper H, Poulsen H et al.: A classification of chronic hepatitis - Lancet 1968;2: 626-628
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnostic, grading and staging - Hepatology 1994; 19: 1513-1520
International Working Party. Terminology of chronic hepatitis, hepatic allograft rejection and nodular lesions of the liver: summary of recommendations developed by an international working party, supported by the World Congresses of Gastroenterology, Los-Angeles, 1994. Am J Gastroenterol 1994; 89: S 177-S 181
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N et al.: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis - Hepatology 1981; 1: 431-435
Ishak K, Baptista A, Bianchi L et al.: Histological grading and staging of hepatitis - J Hepatology 1995; 22: 696-699
Bedossa P: Présentation d’une grille analytique informatisée pour le recueil des lésions histopathologiques dans l’hépatite chronique virale C. Etude coopérative du groupe METAVIR - Ann Pathol 1993; 13: 260-265
Bedossa P., Bioulac-Sage P, Callard P, Chevallier M, Degott C; Deugnier Y, Fabre M, Reynes M, Voigt JJ et Zafrani E: Quelle classification pour les hépatites chroniques ? Les leçons du virus de l’hépatite C - Groupe METAVIR Gastroenterol Clin Biol 1994; 18: 403-406
Davies SE, Portmann BC, O’Grady JG, et al.: hepatic histological findings after liver transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis - Hepatology 1991; 13:150-157
Walker N, Apel R, Kerlin P et al. : Hepatitis B virus infection in liver allografts - Am J Surg Pathol 1993; 17:666-667
O’Grady JG, Smith HM, Davies SE et al.: Hepatitis B reinfection after orthotopic liver transplantation . Serological and clinical implication. J Hepatol 1992;14:104-111
Jamal H, Regenstein F, Farr G, Perillo RP: Prolonged survival in fibrosing cholestatic hepatitis with long-term Ganciclovir therapy - Am J Gastroenterol 1996; 91: 1027-1030
Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J: Hepatitis C viral infection in liver transplant recipients - Hepatology 1992; 16: 865-876
Greenson JK, Svoboda-Newman SM, Merion RM, Frank TS: Histologic progression of recurrent hepatitis C in liver transplant allografts - Am J Surg Pathol 1996; 20: 731-738
Gane EJ, Portmann BC, Naoumov NV et al.: Long-term outcome of hepatitis C infection after liver transplantation - N Eng J Med 1996; 334: 815-820
Dickson RC, Caldwell SH, Ishitani MB et al.: Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation - Transplantation 1996; 61: 701-705
6
Nothing
7
IDEM VHB
8
Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: A preliminary report. N Engl J Med 1986, 315:1575-1578.
Omata M, Yokosuka O, Takano S, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991, 338: 914-915.
Takano S, Satomura Y, Omata M, et al. Effects of interferon beta on non-A, non-B acute hepatitis: A prospective, randomized, controlled-dose study. Gastroenterology 1994, 107:805-811.
Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: A multicenter randomized, controlled trial. N Engl J Med 1989, 321:1501-1505.
Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989, 321:1506-1510.
Marcellin P, Boyer N, Giostra E, et al. Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: A multicenter randomized controlled trial from France. Hepatology 1991, 13:393-397.
Marcellin P. Traitement de l'hépatite C par l'interféron. Gastroenterol Clin Biol. 1997, 20: S81-S88.
Poynard T, Bédossa P, Chevallier M, Mathurin P, Lemonnier C, Trépo C, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 322:1457-62.
Poynard T, Leroy V, Cohard M, Thévenot T, Mathurin P, Opolon P. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24:778-89.
Marcellin P, Pouteau M, Martinot M, Boyer N, Castelnau C, Benhamou JP, et al. Facteurs de réponse au traitement par l'interféron alpha chez les malades atteints d'hépatite chronique C. Perspectives thérapeutiques. Gastroenterol Clin Biol 1995; 19: 991-1000.
VHD
Rizzetto M. et al. Immunofluorescence détection of a nex antigenantibody system (delta/anti-delta) associated with hepatitis B virus in liver and serum of HBsAg carriers. Gut 1977; 18: 997-1003.
Rizzetto M. et al. Chronic HBsAg hepatitis with intrahepatic expression of delta antigen. An active and progressive disease unresponsive to immunosuppressive therapy. Ann Int Med. 1983; 98: 437-41.
Rosian F., Rizzetto M. Treatment of chronic type D (Delta) hepatitis with alpha interféron. Sem Liv Dis. 1989; 9: 264-6.
Farci P., Mandans A. et al. Treatment of chronic hepatitis D with interféron alpha-2b. N Engl J Med. 1994; 330: 88-94.
Ottobrelli A. et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 101: 1649-1655, 1991.
VHE
1Bradley DW. Hepatitis E: epidemiology, aetiology and molecular biology. Reviews in Medical Virology 1992; Vol 2: 19-28.
Vranckx R., Van Damme P, Coenjaerst A. HEV infections in selected Belgian populations. in Enterically-transmitted hepatitis viruses. Ed. Buisson Y, Coursaget P, Kane M. La Simarre, Tours (France)1996, 225-227.
Reyes GR., Purdy MA., Kim JP, Luk KC, Young LM, Fry KE, Bradley DW. Isolation of a CDNA clone from the virus responsable for enterically transmitted non-A, non-B hepatitis. Science 1990; 247:1335-1339.
Tam AW, Smith MM, Guerra ME, HUANG CC, Bradley DW, Fry KE, Reyes GR. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991; 120-131.
Psichogiou MA, Tassopoulos NC, Papatheodoridis GV,
Tzala E, Klarmann R, Mtteler H, Schlauder GG, Troonen H, Hatzakis A.
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis.
J Hepatol 1995; 23: 668-673.
Krawczynski K, Mc Caustland K, Mast E, Yarbough PO,
Purdy M, Favorov MO, Spellbring J. Elements of pathogenesis of hepatitis E infection in man and experimentally infected primates.
in enterically-transmitted hepatitis viruses. Ed. Buisson Y, Coursaget
P, Kane M. La Simarre, Tours (France) 1996, 317-328.
Mast E, Purdy MA, Krawczynski K. Hepatitis E. Baillière's Clinical Gastroenterology. 1996, 10, 227-242.
VHG
Deinhardt F., Peterson D., Cross G, et al. Hepatitis in marmosets. Am J Med Sci 1975; 270: 73-80.
Simons J., Leary T., Dawson G., et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1(6): 19-24.
LinnenJ, Wages J., Zhang-Keck Z., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 43-46.
Alter H., Nakatsuji Y, Mepolder J., et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
Lunel F., Frangeul L., Fretz C., et al. Prevalence of hepatitis G virus infection in a french prospective study on low prevalence of post transfusion hepatitis C. Hepatology 1996; 24(4): 230A.
Goeser T., Seipp S., Wahl R., et al. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C. J Hepatol 1997; 26(3): 498-502.
Diamantis I., Bassetti S., Erb P., et al. High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts. J Hepatol 1997; 26(4): 794-797.
Masuko K., Mitsui T., Iwano K., et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
Feucht H., Zollner B., Polywka S., Laufs R. Vertical transmission of hepatitis G. Lancet 1996; 347: 615-616.
Pawlotsky JM, Germanidis G., Huraux C., et al. Mother-to-infant transmission of GB virus C and HCV in HCV-infected pregnamt women. Hepatology 1996; 24(4): 225A.
Alter M., Gallagher M., Morris T., et al. Acute non A-E hepatitis in the United States and the role of hepatitis G infection.N Engl J Med 1997; 336: 741-746.
Sookoian S., Frider B., Gonzalez J., et al. Detection of GBV-C RNA in patients with acute non A-E hepatitis in Argentina.Hepatology 1996; 24(4): 291A.
Persicol T., Thiers V., Tuveri R., et al. Detection of hepatitis G/GB-C viral RNA but not HCV RNA in the different semen fractions of infected patients. Hepatology 1996; 24(4): 226A.
Halfon P., Bourlière M., Raab J., et al. Molecular analysis of sexual or intrafamilial transmission of hepatitis G virus in HCV-infected couples. J Hepatol 1997; 26(suppl. 1): 180.
Heringlake S., Tillman H., Trautwein C., et al. GBV-C is not the major cause of autoimmune and cryptogenic hepatitis but a certain subtype seems to be frequently associated with fulminant hepatic failure in German patients. Hepatology 1996; 24(4): 290A.
Munoz S., Alter H., Liang T., et al. Hepatitis G virus is present in serum of patients with fulminant hepatitis of unknowm etiology. Hepatology 1996; 24(4): 293A.
Tameda Y., Kosaka Y., Tagawa S., et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996; 25: 842-847.
Saiz J., Sans H., Olmedo E., et al. Hepatitis G virus in,fection in fulminant hepatitis. Hepatology 1996; 24(4): 292A.
Martinot M., Marcellin P., Pouteau M., et al. HGV infection in French patients with chronic hepatitis C. Hepatology 1996; 24(4): 229A.
Pawlotsky JM, Roudot-Thoraval F., Pellerin M, et al. GBV-C infection in HCV-infected patients: epidemiological characteristics, influence on HCV infection and response to interferon alpha therapy.Hepatology 1996; 24(4): 226A.
Saiz J., Ampurdanes S., Olmedo E., et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features, and response to interferon therapy. J Hepâtol 1997; 26: 787-793.
Nakatsuji Y., Shih J., Kobayashi M., et al. Hepatitis G virus infection in Japanese patients infected with hepatitis C virus. Hepatology 1996; 24(4): 227A.
Pilot-Matias T., Carrick R., Coleman P., et al. Anti E2 expression of GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serological marker. Virology 1996; 225: 282-292.
Miyakama Y and Mayumi M. Hepatitis G virus: a true hepatitis virus or an accidental tourist? N Engl J Med 1997; 336: 795-796.
Herpes
1. Lemon SM.
HAV: current concepts of the molecular virology, immunobiology, and approaches to vaccine development. Rev Med Virol, 2, 73-87
2. Feinstone SM, Kapikian AZ, Purcell RH.
Detection by immune electron microscopy of a virus like antigen associated with acute illness.
Science 1973, 182, 1026
3. Gordon S, Reddy K, Schiff L, Schiff ER.
Prolonged intrahepatic cholestasis secondary to acute hepatitis A.
Ann Intern Med, 1984, 101, 635-637
4. Glikson M, Galun E, Oren R, Tur-Kaspa R,
Shouval D.
Relapsing hepatitis A.
Revieuw of 14 cases and literature survey. Medicine, 1992, 71, 14-23
5. Vento S, Garofano T, Di Perri G, Dolci L, Concia R, Bassetti D.
Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis 1 in susceptible individuals.
Lancet, 1991, 337, 1183-1187
6. Andre F, d'Hondt E, Delem A, Safary A.
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine. ;Rationale and summary of findings.Vaccine, 1992, 10, S160-S168